Immunogenicity and associated safety of amtabafusp alfa, a bispecific T-cell engager, in a phase 1b study in people with HIV Immunogenicity and Associated Safety of Amtabafusp Alfa, a Bispecific T Cell Engager, in a Phase 1b Study in People With HIV

Conference Reports for NATAP

HIV Glasgow 2026
8-11 November


Immunogenicity and Associated Safety of Amtabafusp Alfa, a Bispecific T Cell Engager, in a Phase 1b Study in People With HIV (2)

	Glasgow 2026 Nov 8-11